Global Health (Australia) Performance
| GLH Stock | 0.14 0.01 7.69% |
On a scale of 0 to 100, Global Health holds a performance score of 7. The company retains a Market Volatility (i.e., Beta) of 0.0081, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Global Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Global Health is expected to be smaller as well. Please check Global Health's total risk alpha, maximum drawdown, skewness, as well as the relationship between the treynor ratio and potential upside , to make a quick decision on whether Global Health's current trending patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Global Health are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain technical indicators, Global Health unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:15 | Ex Dividend Date 2017-03-01 | Last Split Date 2012-12-03 |
1 | Seres Therapeutics to Participate in Cantor 2024 Global Healthcare Conference - StockTitan | 09/13/2024 |
2 | What a Trump presidency means for global health - The Conversation | 11/11/2024 |
3 | iRhythm Technologies to Present at Citi 2024 Global Healthcare Conference IRTC Stock News - StockTitan | 11/20/2024 |
| Begin Period Cash Flow | 2.2 M |
Global |
Global Health Relative Risk vs. Return Landscape
If you would invest 12.00 in Global Health on August 28, 2024 and sell it today you would earn a total of 2.00 from holding Global Health or generate 16.67% return on investment over 90 days. Global Health is generating 0.2955% of daily returns assuming 3.3109% volatility of returns over the 90 days investment horizon. Simply put, 29% of all stocks have less volatile historical return distribution than Global Health, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Global Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Global Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Global Health, and traders can use it to determine the average amount a Global Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0892
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GLH | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.31 actual daily | 29 71% of assets are more volatile |
Expected Return
| 0.3 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Global Health is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Global Health by adding it to a well-diversified portfolio.
Global Health Fundamentals Growth
Global Stock prices reflect investors' perceptions of the future prospects and financial health of Global Health, and Global Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Global Stock performance.
| Return On Equity | -13.59 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 6.94 M | ||||
| Shares Outstanding | 58.05 M | ||||
| Price To Book | 2.66 X | ||||
| Price To Sales | 0.92 X | ||||
| Revenue | 8.12 M | ||||
| Gross Profit | 511.21 K | ||||
| EBITDA | (1.77 M) | ||||
| Net Income | (1.31 M) | ||||
| Total Debt | 1.03 M | ||||
| Book Value Per Share | (0.05) X | ||||
| Cash Flow From Operations | (1.13 M) | ||||
| Earnings Per Share | (0.02) X | ||||
| Total Asset | 3.08 M | ||||
| Retained Earnings | (30.68 M) | ||||
About Global Health Performance
Assessing Global Health's fundamental ratios provides investors with valuable insights into Global Health's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Global Health is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Global Health is entity of Australia. It is traded as Stock on AU exchange.Things to note about Global Health performance evaluation
Checking the ongoing alerts about Global Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Global Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Global Health has some characteristics of a very speculative penny stock | |
| Global Health had very high historical volatility over the last 90 days | |
| Global Health has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 8.12 M. Net Loss for the year was (1.31 M) with profit before overhead, payroll, taxes, and interest of 511.21 K. | |
| Global Health generates negative cash flow from operations | |
| About 78.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: iRhythm Technologies to Present at Citi 2024 Global Healthcare Conference IRTC Stock News - StockTitan |
- Analyzing Global Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Global Health's stock is overvalued or undervalued compared to its peers.
- Examining Global Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Global Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Global Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Global Health's stock. These opinions can provide insight into Global Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Global Stock Analysis
When running Global Health's price analysis, check to measure Global Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Health is operating at the current time. Most of Global Health's value examination focuses on studying past and present price action to predict the probability of Global Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Health's price. Additionally, you may evaluate how the addition of Global Health to your portfolios can decrease your overall portfolio volatility.